Hubei Goto Biopharm Co.,Ltd.

SZSE:300966.SZ

21.06 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017
Revenue 536.596566.399604.571590.885468.117464.802437.302333.692
Cost of Revenue 431.033450.291466.352434.975361.494333.114306.327231.702
Gross Profit 105.562116.108138.22155.911106.624131.688130.975101.99
Gross Profit Ratio 0.1970.2050.2290.2640.2280.2830.30.306
Reseach & Development Expenses 51.08338.09945.14737.12321.60426.05627.10423.464
General & Administrative Expenses 25.63316.7615.07518.53-6.118-40.602-29.605-14.629
Selling & Marketing Expenses 3.9344.1774.9075.4713.4544.4674.2733.341
SG&A 29.56754.60619.98224.001-2.664-36.135-25.331-11.288
Other Expenses 67.3343.874-0.3923.40510.06536.65831.96119.093
Operating Expenses 147.98496.57985.2983.47340.70538.84344.29339.988
Operating Income -42.42219.5338.90462.71257.379.69578.33355.209
Operating Income Ratio -0.0790.0340.0640.1060.1220.1710.1790.165
Total Other Income Expenses Net -3.113-0.414-0.3923.4052.9423.1172.0530.432
Income Before Tax -45.53519.11638.51486.11760.24282.81180.38655.642
Income Before Tax Ratio -0.0850.0340.0640.1460.1290.1780.1840.167
Income Tax Expense -13.879-2.174-0.9828.0517.0479.8159.7088.203
Net Income -27.59123.00540.20578.33153.28972.99670.67847.439
Net Income Ratio -0.0510.0410.0670.1330.1140.1570.1620.142
EPS -0.240.20.350.680.460.630.841.03
EPS Diluted -0.240.20.350.680.460.630.841.03
EBITDA 21.22860.50579.117116.3988.176104.767100.32869.111
EBITDA Ratio 0.040.1070.1310.1970.1880.2250.2290.207